Articles with public access mandates - Jill HunterLearn more
Available somewhere: 14
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu, I Fernandez, ...
Nature 514 (7520), 112-116, 2014
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
SJ Veuger, JE Hunter, BW Durkacz
Oncogene 28 (6), 832-842, 2009
Mandates: Cancer Research UK
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma
MI Walton, PD Eve, A Hayes, AT Henley, MR Valenti, AKDH Brandon, ...
Oncotarget 7 (3), 2329, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
c-Rel and its many roles in cancer: an old story with new twists
JE Hunter, J Leslie, ND Perkins
British journal of cancer 114 (1), 1-6, 2016
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699
JE Hunter, E Willmore, JAE Irving, Z Hostomsky, SJ Veuger, BW Durkacz
Oncogene 31 (2), 251-264, 2012
Mandates: Cancer Research UK
The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma
JE Hunter, JA Butterworth, B Zhao, H Sellier, KJ Campbell, HD Thomas, ...
Oncogene 35 (26), 3476-3484, 2016
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK …
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia
A Herriott, SJ Tudhope, G Junge, N Rodrigues, MJ Patterson, ...
Oncotarget 6 (41), 43978, 2015
Mandates: Blood Cancer UK, Cancer Research UK, UK Medical Research Council
A RelA (p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer
A Moles, JA Butterworth, A Sanchez, JE Hunter, J Leslie, H Sellier, ...
Oncogene 35 (35), 4623-4632, 2016
Mandates: Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Using body temperature, food and water consumption as biomarkers of disease progression in mice with E μ-myc lymphoma
JE Hunter, J Butterworth, ND Perkins, M Bateson, CA Richardson
British journal of cancer 110 (4), 928-934, 2014
Mandates: Cancer Research UK, Wellcome Trust
Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12
S Sandhu, IF Sou, JE Hunter, L Salmon, CL Wilson, ND Perkins, N Hunter, ...
Communications Biology 4 (1), 1-13, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, UK …
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
JE Hunter, AE Campbell, NL Hannaway, S Kerridge, S Luli, ...
bioRxiv, 2021
Mandates: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
A pseudo-meiotic centrosomal function of TEX12 in cancer
S Sandhu, LJ Salmon, JE Hunter, CL Wilson, ND Perkins, N Hunter, ...
bioRxiv, 509869, 2019
Mandates: Wellcome Trust, Royal Society UK
Regulation of checkpoint kinase signalling and tumorigenesis by the NF-κB regulated gene, CLSPN
JE Hunter, JA Butterworth, H Sellier, S Luli, A Floudas, AJ Moore, ...
bioRxiv, 358291, 2018
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Increased migration and motility in XIAP-null cells mediated by the C-RAF protein kinase
LG Russell, LAK Davis, JE Hunter, ND Perkins, NS Kenneth
Mandates: Cancer Research UK
Publication and funding information is determined automatically by a computer program